Eric W. Thomas

Array ( [id] => 5785448 [patent_doc_number] => 20060205070 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-14 [patent_title] => 'HIV TEV compositions and methods of use' [patent_app_type] => utility [patent_app_number] => 11/364873 [patent_app_country] => US [patent_app_date] => 2006-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 46 [patent_figures_cnt] => 46 [patent_no_of_words] => 27058 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0205/20060205070.pdf [firstpage_image] =>[orig_patent_app_number] => 11364873 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5619428 [patent_doc_number] => 20060188961 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-24 [patent_title] => 'Intergenic regions as novel sites for insertion of HIV DNA sequences in the genome of modified vaccinia virus ankara' [patent_app_type] => utility [patent_app_number] => 11/355948 [patent_app_country] => US [patent_app_date] => 2006-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 19129 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0188/20060188961.pdf [firstpage_image] =>[orig_patent_app_number] => 11355948 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5514721 [patent_doc_number] => 20090215028 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-27 [patent_title] => 'Methods and Compositions for Determining Anti-HIV Drug Susceptibility and Replication Capacity of HIV' [patent_app_type] => utility [patent_app_number] => 11/884668 [patent_app_country] => US [patent_app_date] => 2006-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 20964 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20090215028.pdf [firstpage_image] =>[orig_patent_app_number] => 11884668 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9749597 [patent_doc_number] => 08841068 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-23 [patent_title] => 'Human immunodeficiency virus antiviral screening assay involving the detection of CEM15 expression' [patent_app_type] => utility [patent_app_number] => 11/816063 [patent_app_country] => US [patent_app_date] => 2006-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 15 [patent_no_of_words] => 28040 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11816063 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4785483 [patent_doc_number] => 20080138812 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-12 [patent_title] => 'Screening Method For Competitive Hiv Rt Inhibitors' [patent_app_type] => utility [patent_app_number] => 11/814841 [patent_app_country] => US [patent_app_date] => 2006-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6957 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0138/20080138812.pdf [firstpage_image] =>[orig_patent_app_number] => 11814841 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5667595 [patent_doc_number] => 20060172945 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-03 [patent_title] => 'Human neutrophil alpha-defensin 4 inhibition of HIV-1' [patent_app_type] => utility [patent_app_number] => 11/347538 [patent_app_country] => US [patent_app_date] => 2006-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2991 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20060172945.pdf [firstpage_image] =>[orig_patent_app_number] => 11347538 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4852037 [patent_doc_number] => 20080317779 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-25 [patent_title] => 'Hiv Tat-Cd4 Hybrid Molecules and Methods of Use Thereof' [patent_app_type] => utility [patent_app_number] => 11/883696 [patent_app_country] => US [patent_app_date] => 2006-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 24606 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0317/20080317779.pdf [firstpage_image] =>[orig_patent_app_number] => 11883696 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5700015 [patent_doc_number] => 20060216699 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-28 [patent_title] => 'Peptides for the detection of HIV-1 group O' [patent_app_type] => utility [patent_app_number] => 11/341363 [patent_app_country] => US [patent_app_date] => 2006-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 6975 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20060216699.pdf [firstpage_image] =>[orig_patent_app_number] => 11341363 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9073907 [patent_doc_number] => 08551483 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-08 [patent_title] => 'Methods of treating viral infections by administering KIR2DL-binding antibodies' [patent_app_type] => utility [patent_app_number] => 11/813399 [patent_app_country] => US [patent_app_date] => 2006-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 15588 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11813399 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 836816 [patent_doc_number] => 07393631 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-07-01 [patent_title] => 'Method for purifying adenoviruses' [patent_app_type] => utility [patent_app_number] => 11/326275 [patent_app_country] => US [patent_app_date] => 2006-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3412 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/393/07393631.pdf [firstpage_image] =>[orig_patent_app_number] => 11326275 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4681837 [patent_doc_number] => 20080248063 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-09 [patent_title] => 'Hetero-Oligomeric Hiv Envelope Proteins' [patent_app_type] => utility [patent_app_number] => 11/722336 [patent_app_country] => US [patent_app_date] => 2005-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8284 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0248/20080248063.pdf [firstpage_image] =>[orig_patent_app_number] => 11722336 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 852883 [patent_doc_number] => 07378265 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-05-27 [patent_title] => 'Method of inactivating enveloped viruses in a viral preparation of non-enveloped viruses' [patent_app_type] => utility [patent_app_number] => 11/301160 [patent_app_country] => US [patent_app_date] => 2005-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12935 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 178 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/378/07378265.pdf [firstpage_image] =>[orig_patent_app_number] => 11301160 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5613528 [patent_doc_number] => 20060115456 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-01 [patent_title] => 'Replication-competent adenoviral vectors' [patent_app_type] => utility [patent_app_number] => 11/282319 [patent_app_country] => US [patent_app_date] => 2005-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 16599 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20060115456.pdf [firstpage_image] =>[orig_patent_app_number] => 11282319 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4651028 [patent_doc_number] => 20080038284 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-14 [patent_title] => 'Human Immunodeficiency Virus Vaccine' [patent_app_type] => utility [patent_app_number] => 11/666732 [patent_app_country] => US [patent_app_date] => 2005-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8217 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20080038284.pdf [firstpage_image] =>[orig_patent_app_number] => 11666732 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7811136 [patent_doc_number] => 08133666 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-03-13 [patent_title] => 'Method for identifying agents capable of inhibiting APOBEC3C activity in HIV-infected cells' [patent_app_type] => utility [patent_app_number] => 11/577077 [patent_app_country] => US [patent_app_date] => 2005-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 13 [patent_no_of_words] => 19578 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/133/08133666.pdf [firstpage_image] =>[orig_patent_app_number] => 11577077 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5807695 [patent_doc_number] => 20060094049 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-04 [patent_title] => 'Stabilized viral envelope proteins and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/261390 [patent_app_country] => US [patent_app_date] => 2005-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 19750 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0094/20060094049.pdf [firstpage_image] =>[orig_patent_app_number] => 11261390 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5655242 [patent_doc_number] => 20060140977 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-29 [patent_title] => 'Methods for assaying inhibition of HIV-1 envelope glycoprotein-mediated membrane fusion' [patent_app_type] => utility [patent_app_number] => 11/259540 [patent_app_country] => US [patent_app_date] => 2005-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 15640 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0140/20060140977.pdf [firstpage_image] =>[orig_patent_app_number] => 11259540 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5004555 [patent_doc_number] => 20070202123 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-30 [patent_title] => 'Fusion proteins comprising DP-178 and other viral fusion inhibitor peptides useful for treating aids' [patent_app_type] => utility [patent_app_number] => 11/253274 [patent_app_country] => US [patent_app_date] => 2005-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 84 [patent_figures_cnt] => 84 [patent_no_of_words] => 37528 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20070202123.pdf [firstpage_image] =>[orig_patent_app_number] => 11253274 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 334006 [patent_doc_number] => 07507417 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-03-24 [patent_title] => 'Immunogenic compositions comprising human immunodeficiency virus type 2 (HIV-2) glycosylated and unglycosylated envelope proteins and their methods of preparation' [patent_app_type] => utility [patent_app_number] => 11/235527 [patent_app_country] => US [patent_app_date] => 2005-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 14 [patent_no_of_words] => 13123 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/507/07507417.pdf [firstpage_image] =>[orig_patent_app_number] => 11235527 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7730184 [patent_doc_number] => 08101739 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-24 [patent_title] => 'Recombinant expression vectors comprising a human codon-optimized marburg virus (MARV) angola glycoprotein gene insert and method of immunization employing said vector' [patent_app_type] => utility [patent_app_number] => 11/662869 [patent_app_country] => US [patent_app_date] => 2005-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 57 [patent_no_of_words] => 13308 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/101/08101739.pdf [firstpage_image] =>[orig_patent_app_number] => 11662869 [rel_patent_id] =>[rel_patent_doc_number] =>)